ADENTRI
Facts from the Community
From the BioVenturist base
Developed by:
Stage of development:
We can tell you that ADENTRI is a
If you know more about ADENTRI, you can add more facts here »
Similar topics in Freebase
-
Neublastin
-
LINGO
-
Lixivaptan
-
Lumiliximab
Lumiliximab is a chimeric monoclonal antibody that targets CD23. It acts as an immunomodulator and, as of October 2009, it is being investigated in Phase I and II clinical trials for the treatment of chronic lymphocytic leukemia. -
BG - Anti-TWEAK
-
BG - Long-Acting rFactor IX
You can help improve this topic by adding more facts here